Drug companies like Eli Lilly and Roche are racing to build supercomputers to help fix the 90% failure rate in drug ...

On May 6, the California Supreme Court will hear a case that could upend the economics of medical innovation.

Biosimilar formulation development requires navigating around scientific, regulatory, and legal challenges, according to Sung ...

Order scenario, the current economics of a representative Indian generic programme sit at the edge of viability ...

The growing complexity of the field reinforces the need for standards ensuring product quality, consistency, and patient ...

Hospitals filled to capacity. Case counts climbing by the hour. Quarantine became routine. It was the beginning of the ...

For pharmaceutical and life sciences companies ready to embrace this moment, the 10 principles aren't a burden. They're a ...

SHANGHAI, SHANGHAI, CHINA, April 30, 2026 /EINPresswire.com/ -- In today’s life sciences industry, moving a drug ...

Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") today announced that it will release its financial results for the first quarter of 2026 after the market close on ...

In this Pharma Matters Q&A, Anshul Gupte of PCI Pharma Services discusses investments and opportunities in sterile ...

In part 2 of a multi-part series, David Schoneker, president, Black Diamond Regulatory Consulting, explains what drives the ...

Discover how quality-driven drug development and AI accelerate safer medicines, reduce risk, and improve patient outcomes.